Making THE vaccine
Biochemist
; 43(4):8-13, 2021.
Article
in English
| Scopus | ID: covidwho-1371608
ABSTRACT
The COVID-19 pandemic has caused millions of deaths and devastated communities across the globe. Vaccines will play a key role in bringing the pandemic under control, with successful clinical trials, authorizations and roll-out having now occurred in several countries. However, large-scale manufacturing of such vaccines remains a bottleneck to delivering doses to billions of people at risk of infection, as well as producing new versions of the vaccines that target variants. Here we discuss the current status of manufacturing, focusing on the adenovirus-vectored vaccine developed by the University of Oxford and how the process for manufacturing it was developed. © 2021 The Authors. Published by Portland Press Limited. All Rights Reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Topics:
Vaccines
Language:
English
Journal:
Biochemist
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS